Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • RADX Protein: Influencing the Oncogenic Potential in Humans

Proteome plasticity at high temperatures!

Unveiling the features of within-host dynamics in malaria

RADX Protein: Influencing the Oncogenic Potential in Humans
  • BiotechToday
  • World

RADX Protein: Influencing the Oncogenic Potential in Humans

BioTech Today July 26, 2021July 25, 2021

Saptaparna Dasgupta, Bennett University

Human exonuclease V (EXO5) is an ATR-regulated nuclease that is specific to the DNA structure. It is also associated with BLM, to mark the start point of the replication fork in a strand of DNA. Research states that an elevated level of EXO5 in tumor cells results in increased mutation within the cells. Which thus, leads to poor rates of survival of patients. It therefore can be concluded that a high level of EXO5 is directly influencing the oncogenic potential in humans.

RADX protein:

The RADX protein attracted the attention of researchers as it can have two biologically alternate effects; with only one mechanism of action. David Cortez, Ph.D. professor and chair of Biochemistry said that it is interesting according to him that a protein could switch biological function, without altering its function. RADX is involved at the site of DNA synthesis, the replication fork. Cortez, Ph.D. Chair for Innovation in Biochemistry along with his colleagues made the RADX invention several years ago. Since that time, RADX was associated with the DNA replication mechanism of cells.

Mechanism of fork reversal:

The invention by Cortez et. al, revealed that RADX also regulates the process of fork reversal. It occurs as a backup mechanism in cases of failure of the DNA replication machinery. In the situation of DNA lesions or any other barrier during replication, the cell responds using the mechanism of fork reversal. Also, the occurrence of some kind of barrier during replication was observed often in every cell division cycle. On the contrary, if there are no barriers or DNA lesions at the time of DNA replication, then in those cases the replication fork does not stop or reverses.

The ‘track’ of RADX:

Recent studies by Madison Adolph and Archana Krishnamoorthy, reveal that RADX has different effects on the replication fork. The effects depend on the conditions of the ‘track’ that the replication mechanism follows. They also reported that RADX protein only in cells having stress (lesion or barrier) promotes fork reversal. On the other hand, in the unstressed cells (cells with no lesions or barriers) RADX prevents the process of fork reversal. Thus, it was inferred that RADX works only when it is required by the cells to function.

RAD51 protein:

The researchers discovered the functioning of RADX and concluded that RADX works by binding with RAD51 protein. RAD51 is required only at controlled levels to cause the fork reversal mechanism. This entire process is referred to as a fundamental process in DNA replication and cell division.

Relation of RADX with cancer:

It was reported by Cortez that if the process of DNA synthesis does not happen correctly, then mutations take place, which further results in cancer and development-related disorders. RADX ensures the DNA synthesis process occurs accurately and gets completed. Recent findings state that RADX plays a role in the cell response to chemotherapy. RADX along with BRCA2 protein race with each other for binding on the site of RAD51. BRCA2 is a protein that is associated with the risk of breast and ovarian cancer. Although the role of RADX towards cancer has been tested successfully in vitro, the in vivo results are yet to be discovered.

Also read: Proteome plasticity at high temperatures!

Reference:

  1. Hambarde, S., Tsai, C.-L., Pandita, R. K., Bacolla, A., Maitra, A., Charaka, V., Hunt, C. R., Kumar, R., Limbo, O., Le Meur, R., Chazin, W. J., Tsutakawa, S. E., Russell, P., Schlacher, K., Pandita, T. K., & Tainer, J. A. (2021). EXO5-DNA structure and BLM interactions direct DNA resection critical for ATR-dependent replication restart. Molecular Cell, 81(14), 2989-3006.e9. https://doi.org/10.1016/j.molcel.2021.05.027
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Author info:

Saptaparna Dasgupta, currently a B. Tech 3rd year student, pursuing Biotechnology, is a diligent student and determined in terms of her career goals. Being a budding biotechnologist, she is open to all research fields of her course and passionate about knowledge. She is focused and constantly tries to improve her writing skills, also a project enthusiast and is fond of gaining hands-on experience in laboratories. She believes that all hard works and effort pay off eventually and follows this as the motto of her life.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged BRCA2 protein cancer Cell cycle DNA lesions DNA replication Exonuclease V fork reversal Mutation RAD51 protein RADX protein replication fork

One thought on “RADX Protein: Influencing the Oncogenic Potential in Humans”

  1. Jerry John says:
    July 26, 2021 at 5:42 am

    Well written 💯

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Unveiling the features of within-host dynamics in malaria

BioTech Today July 26, 2021

Avani Dave, Jai Hind College The fidelity of disease model predictions is based on precisely describing the incorporated processes and parameters. Several different models exist and help in describing the dynamics observed in the host during malaria infection. That being said, there is insufficient clinical data that can be utilized for the quantitative validation and […]

dynamics

Related Post

  • BiotechToday
  • World

Stromal cell interaction promotes oxidised redox state of a cancer cell

bioxone October 27, 2020October 27, 2020

Shrestha Dutta, Amity University Kolkata The Tumor microenvironment impacts pancreatic Tumor advancement and progression. Pancreatic Tumor organoid model systems that include stromal cells can be utilized to contemplate the interactions between malignant cells and the supporting stromal cells. The advantage of these systems and optical redox imaging is to show that pancreatic stellate cells (PSCs) […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Seasonal influenza A virus (IAV) vaccines with High-Affinity Antibodies

bioxone January 11, 2021January 11, 2021

Thota Kanishka Rao, Amity University Kolkata Improving the age of comprehensively receptive antibodies against influenza A virus (IAV) is a pertinent objective toward building up a global IAV immunization. While antibodies that bind conserved IAV epitopes have been recognized in people, antibodies specific for the variable epitopes are substantially more predominant than antibodies perceiving conserved […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

National Science Day 2023: History and Significance

BioTech Today February 28, 2023February 28, 2023

Intisar Ahmed, Acharya Prafulla Chandra Collge, WBSU “Ask the right questions, and nature will open the doors to her secrets.”- C.V. Raman The National Science Day is celebrated on the 28th of February every year in our country to give a glance to the great Indian physicist and mathematician Sir Chandrasekhara Venkata Raman, and his enormous […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy